Clinical factors associated with lithium response in bipolar disorders

Australian and New Zealand Journal of Psychiatry

Volumn 51, Issue 5, 2017, Pages 524-530

  Sportiche, Sarah ^a,b,c   Geoffroy, Pierre Alexis ^a,b,c,d   Brichant Petitjean, Clara ^a,b,c   Gard, Sebastien ^c,e   Khan, Jean Pierre ^c,f,g   Azorin, Jean Michel ^c,h,i   Henry, Chantal ^a,c,j   Leboyer, Marion ^a,c   Etain, Bruno ^a,b,c,d   Scott, Jan ^k,l   Bellivier, Frank ^a,b,c,d  

^a INSERM   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c FONDATION FONDAMENTAL   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e CENTRE HOSPITALIER CHARLES PERRENS   (France)

^f UNIVERSITY HOSPITAL OF NANCY   (France)

^g UNIVERSITÉ DE LORRAINE   (France)

^h HÔPITAL SAINTE MARGUERITE   (France)

ⁱ TIMONE HOSPITAL   (France)

^j INSTITUT PASTEUR   (France)

^k NEWCASTLE UNIVERSITY   (United Kingdom)

^l KING'S COLLEGE LONDON   (United Kingdom)

more..

Author keywords

alcohol misuse; Bipolar disorder; clinical predictors; lithium response; mixed state

Indexed keywords

LITHIUM; LITHIUM DERIVATIVE; TRANQUILIZER;

ADULT; ALCOHOLISM; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL ASSESSMENT; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PREDICTION; PSYCHOSIS; SUICIDE ATTEMPT; TREATMENT DURATION; BIPOLAR DISORDER; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PROCEDURES;

ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; FEMALE; HUMANS; LITHIUM COMPOUNDS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 84991638227     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867416664794     Document Type: Article

References (43)

1. Aagaard J, Vestergaard P, (1990) Predictors of outcome in prophylactic lithium treatment: A 2-year prospective study. Journal of Affective Disorders 18: 259-266.
2. American Psychiatric Association (1994) Diagnostic and Statistical Manuel of Mental Disorder, 4th Edition. Arlington, VA: American Psychiatric Publishing.
3. BALANCE Investigators and Collaborators, Geddes JR, Goodwin GM, et al. (2010) Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): A randomised open-label trial. The Lancet 375 (9712): 385-395.
4. Baldessarini RJ, Tondo L, (2000) Does lithium treatment still work? Evidence of stable responses over three decades. Archives of General Psychiatry 57: 187-190.
5. Bech P, Rafaelsen OJ, Kramp P, et al. (1978) The Mania Rating Scale: Scale construction and inter-observer agreement. Neuropharmacology 17: 430-431.
6. Carvalho AF, Dimellis D, Gonda X, et al. (2014) Rapid cycling in bipolar disorder: A systematic review. The Journal of Clinical Psychiatry 75: 578-586.
7. Cipriani A, Pretty H, Hawton K, et al. (2005) Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: A systematic review of randomized trials. The American Journal of Psychiatry 162: 1805-1819.
8. Collins PY, Patel V, Joestl SS, et al. (2011) Grand challenges in global mental health. Nature 475: 27-30.
9. Duffy A, Alda M, Kutcher S, et al. (2002) A prospective study of the offspring of bipolar parents responsive and nonresponsive to lithium treatment. The Journal of Clinical Psychiatry 63: 1171-1178.
10. Feinman JA, Dunner DL, (1996) The effect of alcohol and substance abuse on the course of bipolar affective disorder. Journal of Affective Disorders 37: 43-49.
11. Fountoulakis KN, Kontis D, Gonda X, et al. (2012) Treatment of mixed bipolar states. The International Journal of Neuropsychopharmacology 15: 1015-1026.
12. Freeman TW, Clothier JL, Pazzaglia P, et al. (1992) A double-blind comparison of valproate and lithium in the treatment of acute mania. The American Journal of Psychiatry 149: 108-111.
13. Frye MA, Altshuler LL, McElroy SL, et al. (2003) Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder. The American Journal of Psychiatry 160: 883-889.
14. Frye MA, Salloum IM, (2006) Bipolar disorder and comorbid alcoholism: Prevalence rate and treatment considerations. Bipolar Disorders 8: 677-685.
15. Garnham J, Munro A, Slaney C, et al. (2007) Prophylactic treatment response in bipolar disorder: Results of a naturalistic observation study. Journal of Affective Disorders 104: 185-190.
16. Geddes JR, Burgess S, Hawton K, et al. (2004) Long-term lithium therapy for bipolar disorder: Systematic review and meta-analysis of randomized controlled trials. The American Journal of Psychiatry 161: 217-222.
17. Goodwin FK, Jamison KR, (2007) Manic-Depressive Illness. New York: Oxford University Press.
18. Goodwin FK, Fireman B, Simon GE, et al. (2003) Suicide risk in bipolar disorder during treatment with lithium and divalproex. Journal of American Medical Association 290: 1467-1473.
19. Grof P, (2010) Sixty years of lithium responders. Neuropsychobiology 62: 8-16.
20. Grof P, Duffy A, Cavazzoni P, et al. (2002) Is response to prophylactic lithium a familial trait? The Journal of Clinical Psychiatry 63: 942-947.
21. Hayes JF, Miles J, Walters K, et al. (2015) A systematic review and meta-analysis of premature mortality in bipolar affective disorder. Acta Psychiatrica Scandinavica 131: 417-425.
22. Kessing LV, Hellmund G, Andersen PK, (2011) Predictors of excellent response to lithium: Results from a nationwide register-based study. International Clinical Psychopharmacology 26: 323-328.
23. Kleindienst N, Engel R, Greil W, (2005) Which clinical factors predict response to prophylactic lithium? A systematic review for bipolar disorders. Bipolar Disorders 7: 404-417.
24. Lopez AD, Murray CC, (1998) The global burden of disease, 1990-2020. Nature Medicine 4: 1241-1243.
25. Maj M, Arena F, Lovero N, et al. (1985) Factors associated with response to lithium prophylaxis in DSM III major depression and bipolar disorder. Pharmacopsychiatry 18: 309-313.
26. Manchia M, Adli M, Akula N, et al. (2013) Assessment of response to lithium maintenance treatment in bipolar disorder: A consortium on lithium genetics (ConLiGen) report. PLoS ONE 8: 65636.
27. Mendlewicz J, Fieve RR, Stallone F, (1973) Relationship between the effectiveness of lithium therapy and family history. The American Journal of Psychiatry 130: 1011-1013.
28. Montgomery SA, Asberg M, (1979) A new depression scale designed to be sensitive to change. The British Journal of Psychiatry 134: 382-389.
29. Montgomery SA, Schatzberg AF, Guelfi JD, et al. (2000) Pharmacotherapy of depression and mixed states in bipolar disorder. Journal of Affective Disorders 59: S39-S56.
30. Müller-Oerlinghausen BT, Wolf B, Ahrens B, et al. (1994) Mortality during initial and during later lithium treatment: A collaborative study by the international group for the study of lithium-treated patients. Acta Psychiatrica Scandinavica 90: 295-297.
31. Nascimento NF, Carlson KN, Amaral DN, et al. (2015) Alcohol and lithium have opposing effects on the period and phase of the behavioral free-running activity rhythm. Alcohol 49: 367-376.
32. National Institute for Health and Care Excellence (NICE) (2014) The assessment and management of bipolar disorder in adults, children and young people in primary and secondary care, updated edition. London. Available at: www.nice.org.uk
33. Nurnberger JI, Blehar MC, Kaufmann CA, et al. (1994) Diagnostic interview for genetic studies: Rationale, unique features, and training. NIMH genetics initiative. Archives of General Psychiatry 51: 849-859.
34. O'Connell RA, Mayo JA, Flatow L, et al. (1991) Outcome of bipolar disorder on long-term treatment with lithium. The British Journal of Psychiatry 159: 123-129.
35. Paykel E, Abbott R, Morriss R, et al. (2006) Sub-syndromal and syndromal symptoms in the longitudinal course of bipolar disorder. The British Journal of Psychiatry 189: 118-123.
36. Pfennig A, Schlattmann P, Alda M, et al. (2010) Influence of atypical features on the quality of prophylactic effectiveness of long-term lithium treatment in bipolar disorders. Bipolar Disorders 12: 390-396.
37. Rybakowski JK, Chlopocka-Wozniak M, Suwalska A, (2001) The prophylactic effect of long-term lithium administration in bipolar patients entering treatment in the 1970s and 1980s. Bipolar Disorders 3: 63-67.
38. Schulze TG, Alda M, Adli M, et al. (2010) The International Consortium on Lithium Genetics (ConLiGen): An initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. Neuropsychobiology 62: 72-78.
39. Severus E, Taylor MJ, Sauer C, et al. (2014) Lithium for prevention of mood episodes in bipolar disorders: Systematic review and meta-analysis. International Journal of Bipolar Disorders 2: 15.
40. Teter CJ, Falone AE, Bakaian AM, et al. (2011) Medication adherence and attitudes in patients with bipolar disorder and current versus past substance use disorder. Psychiatry Research 190: 253-258.
41. Tohen M, Waternaux CM, Tsuang MT, et al. (1990) Four-year follow-up of twenty-four first-episode manic patients. Journal of Affective Disorders 19: 79-86.
42. Winokur G, Turvey C, Akiskal H, et al. (1998) Alcoholism and drug abuse in three groups-Bipolar I, unipolars and their acquaintances. Journal of Affective Disorders 50: 81-89.
43. Yatham LN, Fountoulakis KN, Rahman Z, et al. (2013) Efficacy of aripiprazole versus placebo as adjuncts to lithium or valproate in relapse prevention of manic or mixed episodes in bipolar I patients stratified by index manic or mixed episode. Journal of Affective Disorders 147: 365-372.